glp-1 parkinson's disease lancet Are diabetes drugs like Ozempic coming for disease? — Parkinson Secrets Beyond insulin: The Intriguing role

No, youre not automatically guaranteed to get retatrutide in a clinical trial

Bendotti, G

Retatrutides safety profile demonstrated tolerable side effects, predominantly gastrointestinal disturbances, underscoring the need for patient guidance and monitoring

Despite these associations, catestatin has received limited attention as a therapeutic candidate, in part because it does not conform neatly to classical endocrine paradigms and lacks a single dominant receptor target

Gao L, Huang H, Zhang L, Zhang N, Fu Y, Zhu D, et al

These reductions appeared partially independent of weight loss, suggesting potential direct anti-inflammatory effects